in News
Remicade Given FDA Approval to Treat Ulcerative Colitis in Children
Infliximab (Remicade), a tumor necrosis factor (TNF) blocker, has been given FDA approval for use in children. The drug is used in the treatment of moderate to severe ulcerative colitis and has been approved for use in patients older than six who have not responded to conventional treatments. The decision to allow the drug to […] More